<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font17">TRPM </span>
   <span class="font14">for </span>
   <span class="font14">[]. </span>
   <span class="font13">with </span>
   <span class="font13">that </span>
   <span class="font12">The </span>
   <span class="font12">(Figure </span>
   <span class="font12">Figure </span>
   <span class="font12">was </span>
   <span class="font11">channel </span>
   <span class="font11">channels </span>
   <span class="font11">these </span>
   <span class="font11">{background </span>
   <span class="font11">this </span>
   <span class="font11">activity </span>
   <span class="font11">also </span>
   <span class="font11">potent </span>
   <span class="font11">receptor </span>
   <span class="font11">new </span>
   <span class="font11">potential </span>
   <span class="font11">Number </span>
   <span class="font11">compound </span>
   <span class="font11">compounds </span>
   <span class="font11">derivatives </span>
   <span class="font11">[], </span>
   <span class="font11">are </span>
   <span class="font11">different </span>
   <span class="font11">from </span>
   <span class="font11">have </span>
   <span class="font11">margin </span>
   <span class="font11">such </span>
   <span class="font10">activation </span>
   <span class="font10">other </span>
   <span class="font10">{border-style </span>
   <span class="font10">not </span>
   <span class="font10">treatment </span>
   <span class="font10">binding </span>
   <span class="font10">px;} </span>
   <span class="font10">were </span>
   <span class="font10">which </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">agonist </span>
   <span class="font10">antagonists </span>
   <span class="font10">menthol </span>
   <span class="font10">agonists </span>
   <span class="font10">been </span>
   <span class="font10">cold </span>
   <span class="font10">could </span>
   <span class="font10">described </span>
   <span class="font10">induced </span>
   <span class="font10">studies </span>
   <span class="font10">two </span>
   <span class="font10">while </span>
   <span class="font10">effect </span>
   <span class="font10">pain </span>
   <span class="font10">transient </span>
   <span class="font10">Med. </span>
   <span class="font10">bladder </span>
   <span class="font10">both </span>
   <span class="font10">human </span>
   <span class="font10">identified </span>
   <span class="font10">its </span>
   <span class="font10">more </span>
   <span class="font10">(EC </span>
   <span class="font10">Potential </span>
   <span class="font10">This </span>
   <span class="font10">al. </span>
   <span class="font10">containing </span>
   <span class="font10">cooling </span>
   <span class="font10">ion </span>
   <span class="font10">role </span>
   <span class="font10">selective </span>
   <span class="font10">showed </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">(TRPM) </span>
   <span class="font10">Receptor </span>
   <span class="font10">[,]. </span>
   <span class="font10">between </span>
   <span class="font10">nM, </span>
   <span class="font10">residue </span>
   <span class="font10">series </span>
   <span class="font10">structure </span>
   <span class="font10">used </span>
   <span class="font10">activated </span>
   <span class="font10">cell </span>
   <span class="font10">effects </span>
   <span class="font10">group </span>
   <span class="font10">melastatin </span>
   <span class="font10">nerve </span>
   <span class="font10">novel </span>
   <span class="font10">related </span>
   <span class="font10">Channel </span>
   <span class="font10">TRPV </span>
   <span class="font10">Transient </span>
   <span class="font10">among </span>
   <span class="font10">but </span>
   <span class="font10">cells </span>
   <span class="font10">increased </span>
   <span class="font10">modulators </span>
   <span class="font10">most </span>
   <span class="font10">recent </span>
   <span class="font10">ring </span>
   <span class="font10">some </span>
   <span class="font10">will </span>
   <span class="font10">Biol. </span>
   <span class="font10">TRP </span>
   <span class="font10">TRPM, </span>
   <span class="font10">addition, </span>
   <span class="font10">antagonist </span>
   <span class="font10">antagonists, </span>
   <span class="font10">cancer </span>
   <span class="font10">clinical </span>
   <span class="font10">domain </span>
   <span class="font10">effective </span>
   <span class="font10">family </span>
   <span class="font10">has </span>
   <span class="font10">models </span>
   <span class="font10">pore </span>
   <span class="font10">px; </span>
   <span class="font10">rat </span>
   <span class="font10">series, </span>
   <span class="font10">useful </span>
   <span class="font10">values </span>
   <span class="font10">well </span>
   <span class="font10">{font-family </span>
   <span class="font10">(IC </span>
   <span class="font10">However, </span>
   <span class="font10">Melastatin </span>
   <span class="font10">PIP </span>
   <span class="font10">These </span>
   <span class="font10">Thus, </span>
   <span class="font10">active </span>
   <span class="font10">allodynia </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">aromatic </span>
   <span class="font10">associated </span>
   <span class="font10">claimed </span>
   <span class="font10">drug </span>
   <span class="font10">font-size </span>
   <span class="font10">groups </span>
   <span class="font10">highly </span>
   <span class="font10">inhibition </span>
   <span class="font10">interaction </span>
   <span class="font10">interactions </span>
   <span class="font10">natural </span>
   <span class="font10">pharmacological </span>
   <span class="font10">reported </span>
   <span class="font10">skin </span>
   <span class="font10">study </span>
   <span class="font10">suggested </span>
   <span class="font10">through </span>
   <span class="font10">transmembrane </span>
   <span class="font10">type </span>
   <span class="font10">without </span>
   <span class="font10">TRPV, </span>
   <span class="font10">afferent </span>
   <span class="font10">authors </span>
   <span class="font10">cation </span>
   <span class="font10">demonstrated </span>
   <span class="font10">derivative </span>
   <span class="font10">double; </span>
   <span class="font10">dry </span>
   <span class="font10">good </span>
   <span class="font10">important </span>
   <span class="font10">inhibited </span>
   <span class="font10">knowledge </span>
   <span class="font10">low </span>
   <span class="font10">menthol, </span>
   <span class="font10">model </span>
   <span class="font10">modulation </span>
   <span class="font10">nanomolar </span>
   <span class="font10">previous </span>
   <span class="font10">protein </span>
   <span class="font10">results </span>
   <span class="font10">sensory </span>
   <span class="font10">several </span>
   <span class="font10">suggesting </span>
   <span class="font10">target </span>
   <span class="font10">therapeutic </span>
   <span class="font10">they </span>
   <span class="font10">vivo </span>
   <span class="font10">wet-dog </span>
   <span class="font10">Biophys. </span>
   <span class="font10">Chem../acs.jmedchem.b </span>
   <span class="font10">PZQ </span>
   <span class="font10">TRPMFA </span>
   <span class="font10">able </span>
   <span class="font10">acid </span>
   <span class="font10">agonists, </span>
   <span class="font10">allosteric </span>
   <span class="font10">amino </span>
   <span class="font10">antagonist, </span>
   <span class="font10">antagonists. </span>
   <span class="font10">body </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">channel, </span>
   <span class="font10">channels, </span>
   <span class="font10">chronic </span>
   <span class="font10">complex </span>
   <span class="font10">corresponding </span>
   <span class="font10">electron </span>
   <span class="font10">epithelial </span>
   <span class="font10">expression </span>
   <span class="font10">eye </span>
   <span class="font10">first </span>
   <span class="font10">groups, </span>
   <span class="font10">hTRPM </span>
   <span class="font10">helices </span>
   <span class="font10">high </span>
   <span class="font10">hyperactivity </span>
   <span class="font10">icilin </span>
   <span class="font10">icilin-induced </span>
   <span class="font10">identification </span>
   <span class="font10">interesting </span>
   <span class="font10">led </span>
   <span class="font10">micromolar </span>
   <span class="font10">neurons </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">phenyl </span>
   <span class="font10">presence </span>
   <span class="font10">range </span>
   <span class="font10">rats </span>
   <span class="font10">recently </span>
   <span class="font10">residues </span>
   <span class="font10">same </span>
   <span class="font10">search </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">structural </span>
   <span class="font10">structures </span>
   <span class="font10">temperature </span>
   <span class="font10">times </span>
   <span class="font10">use </span>
   <span class="font10">via </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Chem. </span>
   <span class="font10">For </span>
   <span class="font10">Molecular </span>
   <span class="font10">Neurosci../JNEUROSCI.-. </span>
   <span class="font10">Res. </span>
   <span class="font10">TRPA, </span>
   <span class="font10">They </span>
   <span class="font10">all </span>
   <span class="font10">amide </span>
   <span class="font10">analogue </span>
   <span class="font10">application </span>
   <span class="font10">aryl </span>
   <span class="font10">best </span>
   <span class="font10">biology </span>
   <span class="font10">bold </span>
   <span class="font10">calcium </span>
   <span class="font10">cells, </span>
   <span class="font10">changes </span>
   <span class="font10">channels. </span>
   <span class="font10">combination </span>
   <span class="font10">compositions </span>
   <span class="font10">concentrations </span>
   <span class="font10">conditions </span>
   <span class="font10">courier; </span>
   <span class="font10">development </span>
   <span class="font10">discovery </span>
   <span class="font10">due </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">essential </span>
   <span class="font10">found </span>
   <span class="font10">four </span>
   <span class="font10">function </span>
   <span class="font10">functional </span>
   <span class="font10">having </span>
   <span class="font10">homology </span>
   <span class="font10">hypersensitivity </span>
   <span class="font10">icilin, </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibits </span>
   <span class="font10">interest </span>
   <span class="font10">intracellular </span>
   <span class="font10">involved </span>
   <span class="font10">key </span>
   <span class="font10">last </span>
   <span class="font10">located </span>
   <span class="font10">mechanical </span>
   <span class="font10">member </span>
   <span class="font10">models, </span>
   <span class="font10">molecular </span>
   <span class="font10">neuropathic </span>
   <span class="font10">observed </span>
   <span class="font10">ocular </span>
   <span class="font10">one </span>
   <span class="font10">only </span>
   <span class="font10">our </span>
   <span class="font10">patients </span>
   <span class="font10">phase </span>
   <span class="font10">potency </span>
   <span class="font10">primary </span>
   <span class="font10">proposed </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently, </span>
   <span class="font10">receptors </span>
   <span class="font10">reduced </span>
   <span class="font10">resulted </span>
   <span class="font10">screening </span>
   <span class="font10">segments </span>
   <span class="font10">selectivity </span>
   <span class="font10">short </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">site </span>
   <span class="font10">sites </span>
   <span class="font10">syndrome </span>
   <span class="font10">there </span>
   <span class="font10">three </span>
   <span class="font10">thus </span>
   <span class="font10">tract </span>
   <span class="font10">treatments </span>
   <span class="font10">types </span>
   <span class="font10">urea </span>
   <span class="font10">voltage </span>
   <span class="font10">when </span>
  </p>
 </body>
</html>
